Mohammadmoradi, 2023 - Google Patents
The Role of High Mobility Group Box-1 Pathobiology in Angiotensin II-induced Abdominal Aortic AneurysmsMohammadmoradi, 2023
View PDF- Document ID
- 6515002879812698585
- Author
- Mohammadmoradi S
- Publication year
External Links
Snippet
Abdominal aortic aneurysms (AAAs) are permanent luminal dilations of the vessel wall that can result in rupture and death. There is currently no evidence-based treatment to prevent or attenuate the development of this devastating condition. Although vascular inflammation is …
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Yu et al. | High level of uric acid promotes atherosclerosis by targeting NRF2‐Mediated autophagy dysfunction and ferroptosis | |
Morrow et al. | Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemia | |
Knorr et al. | The NLRP3 inflammasome in alcoholic and nonalcoholic steatohepatitis | |
RU2636820C2 (en) | Methods and applications of inhibitors of proprotein convertase subtilisin/kexin, type 9 (pcsk9) | |
Boyapati et al. | Advances in the understanding of mitochondrial DNA as a pathogenic factor in inflammatory diseases | |
Witzenbichler et al. | Protective role of angiopoietin-1 in endotoxic shock | |
Muralidharan et al. | Cellular stress response and innate immune signaling: integrating pathways in host defense and inflammation | |
Li et al. | Salvianolic acid B attenuates rat hepatic fibrosis via downregulating angiotensin II signaling | |
Krishnan‐Sivadoss et al. | Heat shock protein 60 and cardiovascular diseases: An intricate love‐hate story | |
Hsu et al. | Glutathione peroxidase 8 negatively regulates caspase‐4/11 to protect against colitis | |
Li et al. | Human kallistatin administration reduces organ injury and improves survival in a mouse model of polymicrobial sepsis | |
Bayardo et al. | Transglutaminase 2 expression is enhanced synergistically by interferon-γ and tumour necrosis factor-α in human small intestine | |
Li et al. | PCSK9: A key factor modulating atherosclerosis | |
Zhou et al. | Dusp6 deficiency attenuates neutrophil-mediated cardiac damage in the acute inflammatory phase of myocardial infarction | |
Kuroda et al. | Apoptotic response through a high mobility box 1 protein-dependent mechanism in LPS/GalN-induced mouse liver failure and glycyrrhizin-mediated inhibition | |
Zhong et al. | Genipin reverses HFD-induced liver damage and inhibits UCP2-mediated pyroptosis in mice | |
Peng et al. | Inhibition of cathepsin S attenuates myocardial ischemia/reperfusion injury by suppressing inflammation and apoptosis | |
Chang et al. | Inhibition on CXCL5 reduces aortic matrix metalloproteinase 9 expression and protects against acute aortic dissection | |
Qin et al. | Hepatocyte NLRP3 interacts with PKCε to drive hepatic insulin resistance and steatosis | |
Xiao et al. | Protocatechuic acid attenuates cerebral aneurysm formation and progression by inhibiting TNF-alpha/Nrf-2/NF-kB-mediated inflammatory mechanisms in experimental rats | |
Yu et al. | MIR-190B alleviates cell autophagy and burn-induced skeletal muscle wasting via modulating PHLPP1/Akt/FoxO3A signaling pathway | |
Li et al. | Oxymatrine attenuates TNBS-induced colinutis in rats through TLR9/Myd88/NF-κB signal pathway | |
Ling et al. | Jinwujiangu Capsule Treats Fibroblast‐Like Synoviocytes of Rheumatoid Arthritis by Inhibiting Pyroptosis via the NLRP3/CAPSES/GSDMD Pathway | |
Ma et al. | Gasdermin D deficiency does not protect mice from high‐fat diet‐induced glucose intolerance and adipose tissue inflammation | |
Peng et al. | Endoplasmic reticulum stress: a vital process and potential therapeutic target in chronic obstructive pulmonary disease |